A novel cannabinoid type 2 receptor (CB2R) ligand that binds to microglial and immuno cells could be a hit for neuro-inflammatory imaging, according to a study published in the August 2013 issue of Molecular Imaging and Biology. {read more here}

An estimated 30 percent of epileptics experience drug resistance. A PET agent may one day be used to track physiological mechanisms of resistance, according to a study published online Oct. 3 in the Journal of Nuclear Medicine. {read more here}

There is growing interest in applying molecular imaging techniques for the detection of peripheral vascular disease (PVD). A range of scanner-tracer combinations can be used for perfusion, angiogenesis and atherosclerotic imaging, according to a review published online Oct. 7 in the Journal of Nuclear Medicine. {read more here}

Molecular imaging has vast potential to improve healthcare in the coming years by allowing more directed, personalized therapy. But molecular imaging’s contribution may be limited until more imaging specialists are trained to interpret scans acquired with the new types of tracers being developed.  This conundrum is one of many challenges facing molecular medicine in a wide-ranging discussion of the technology between AuntMinnie.com and three molecular imaging experts during last month’s World Molecular Imaging Society (WMIS) annual meeting. {read more here}